Cargando…

Correction Notice: Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849417/
https://www.ncbi.nlm.nih.gov/pubmed/35187409
http://dx.doi.org/10.1097/HS9.0000000000000698
_version_ 1784652461485588480
collection PubMed
description
format Online
Article
Text
id pubmed-8849417
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-88494172022-02-18 Correction Notice: Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A Hemasphere Correction Notice Lippincott Williams & Wilkins 2022-02-15 /pmc/articles/PMC8849417/ /pubmed/35187409 http://dx.doi.org/10.1097/HS9.0000000000000698 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Correction Notice
Correction Notice: Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A
title Correction Notice: Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A
title_full Correction Notice: Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A
title_fullStr Correction Notice: Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A
title_full_unstemmed Correction Notice: Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A
title_short Correction Notice: Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A
title_sort correction notice: modeling benefits, costs, and affordability of a novel gene therapy in hemophilia a
topic Correction Notice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849417/
https://www.ncbi.nlm.nih.gov/pubmed/35187409
http://dx.doi.org/10.1097/HS9.0000000000000698